High-frequency spinal cord stimulation in failed back surgery syndrome patients with predominant low back pain-single-center experience.
Adjacent segment disease
FBSS
High-frequency SCS
Low back pain
Neuromodulation
SCS
Journal
Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
25
08
2020
accepted:
16
11
2020
revised:
27
10
2020
pubmed:
18
1
2021
medline:
16
10
2021
entrez:
17
1
2021
Statut:
ppublish
Résumé
Treatment of patients with failed back surgery syndrome (FBSS) with predominant low back pain (LBP) remains challenging. High-frequency spinal cord stimulation (HF10 SCS) is believed to achieve significant pain reduction. We aimed to evaluate the real-life efficacy of HF-10 SCS in a tertiary spine center. A prospective observational study of all patients with FBSS and predominant LBP who underwent HF-10 SCS surgery was performed between 2016 and 2018. Patients > 18 years with Visual Analogue Scale (VAS) scores of ≥ 5 for LBP and pain duration > 6 months under stable medication were implanted percutaneous under general anesthesia and a trial phase of 7-14 days was accomplished. Primary end point was a successful trial defined as ≥ 50% VAS score reduction for LBP. Thirty-four of 39 (85%) subjects had a successful trial. Fifty-three percent were female and the mean age was 69 years. Median follow-up lasted for 10 months. Devices were removed after a median of 10 months in 5 cases. Remaining 29 patients stated significant VAS score reduction for LBP from 8.1 to 2.9 and VAS for leg pain from 4.9 to 2.2. Twenty-four percent of all patients were able to discontinue their opioids. Eight of 9 patients (89%) with signs of adjacent disc disease and 7 of 10 (70%) patients with hardware failure were successfully implanted with significant VAS reduction for LBP. HF-10 SCS achieves significant pain reduction in most patients with FBSS and predominant LBP. It might be an efficient alternative to revision surgery.
Identifiants
pubmed: 33454835
doi: 10.1007/s10143-020-01462-5
pii: 10.1007/s10143-020-01462-5
pmc: PMC8490248
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2809-2818Informations de copyright
© 2021. The Author(s).
Références
Neurosurgery. 2007 Aug;61(2):361-8; discussion 368-9
pubmed: 17762749
Health Qual Life Outcomes. 2018 Apr 19;16(1):68
pubmed: 29673357
N Engl J Med. 2016 Apr 14;374(15):1413-23
pubmed: 27074066
Pain Physician. 2013 Apr;16(2 Suppl):S49-283
pubmed: 23615883
Br J Pain. 2013 Feb;7(1):56-9
pubmed: 26516498
Neuromodulation. 2018 Jul;21(5):457-465
pubmed: 29608229
Pain Med. 2014 Mar;15(3):347-54
pubmed: 24308759
J Pain Res. 2016 Jul 01;9:481-92
pubmed: 27445503
Spine (Phila Pa 1976). 2017 Jul 15;42 Suppl 14:S41-S52
pubmed: 28505029
Expert Rev Med Devices. 2018 Jan;15(1):61-70
pubmed: 29249191
Anesthesiology. 2015 Oct;123(4):851-60
pubmed: 26218762
Neuromodulation. 2018 Jan;21(1):10-18
pubmed: 29105244
Spine (Phila Pa 1976). 2015 Nov;40(21):1674-80
pubmed: 26267823
J Clin Neurosci. 2016 Jan;23:44-50
pubmed: 26282154
Neurosurgery. 2005;56(1):98-106; discussion 106-7
pubmed: 15617591
J Pain Symptom Manage. 2006 Apr;31(4 Suppl):S25-9
pubmed: 16647592
Curr Pain Headache Rep. 2019 Mar 14;23(4):25
pubmed: 30868285